ZTS

SEC source: 0001555280-16-000474 · wf-form4_147675492284314.xml · derivative · entry 1

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,670.9016

Underlying: Common Stock · 126.9229 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

SEC source: 0001555280-18-000186 · wf-form4_152833057365909.xml · nonDerivative · entry 1

Sanjay Khosla · CIK 0001387531 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7

SEC source: 0001555280-16-000461 · wf-form4_147553100445420.xml · derivative · entry 1

STEERE WILLIAM C JR · CIK 0001033870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,186.5071

Underlying: Common Stock · 490.0039 shares

Expires not disclosed

F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon).

F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

SEC source: 0001555280-16-000460 · wf-form4_147553098538644.xml · derivative · entry 1

PARENT LOUISE M · CIK 0001209456 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,437.761

Underlying: Common Stock · 490.0039 shares

Expires not disclosed

F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon).

F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

SEC source: 0001555280-16-000456 · wf-form4_147371358740389.xml · derivative · entry 1

Fenton Andrew · CIK 0001538226 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,006.4919

Underlying: Common Stock · 1.8125 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

SEC source: 0001555280-16-000454 · wf-form4_147320351635887.xml · nonDerivative · entry 1

MCCALLISTER MICHAEL B · CIK 0001018657 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By trust

Disclosed balance after: 9,000

F1 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.21 to $51.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: Shares held in the Michael B. McCallister Revocable Trust, of which the reporting person is settlor, trustee and beneficiary.

SEC source: 0000899243-16-019598 · doc4.xml · nonDerivative · entry 1

Pershing Square Capital Management, L.P. · CIK 0001336528 · Director

PS Management GP, LLC · CIK 0001336477 · Director

ACKMAN WILLIAM A · CIK 0001056513 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 24,973,145

F1 · ownership.nature: In addition to Pershing Square Capital Management, L.P., a Delaware limited partnership ("Pershing Square"), this Form 4 is being filed jointly by PS Management GP, LLC, a Delaware limited liability company ("PS Management"), and William A. Ackman, a citizen of the United States of America (collectively, the "Reporting Persons"), each of whom has the same business address as Pershing Square and may be deemed to have a pecuniary interest in securities reported on this Form 4 (the "Subject Securities").

F2 · ownership.nature: Pershing Square advises the accounts of Pershing Square, L.P., a Delaware limited partnership ("PS"), Pershing Square II, L.P., a Delaware limited partnership ("PS II"), Pershing Square International, Ltd., a Cayman Islands exempted company ("PS International"), and Pershing Square Holdings, Ltd., a limited liability company incorporated in Guernsey ("PSH" and together with PS, PS II and PS International, the "Pershing Square Funds").

F3 · ownership.nature: Pershing Square, as the investment adviser to the Pershing Square Funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. As the general partner of Pershing Square, PS Management may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Ackman's position as Chief Executive Officer of Pershing Square and managing member of PS Management, Mr. Ackman may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

F4 · ownership.nature: Mr. Doyle, a member of the board of directors of the Issuer, was elected to that board as a representative of Pershing Square, PS Management, the Pershing Square Funds and Pershing Square GP, LLC. As a result, each of those entities are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934.

SEC source: 0000899243-15-000173 · doc4.xml · nonDerivative · entry 2

Pershing Square Capital Management, L.P. · CIK 0001336528 · Director

PS Management GP, LLC · CIK 0001336477 · Director

ACKMAN WILLIAM A · CIK 0001056513 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 41,823,145

F4 · kind: This Form 4 is being filed as a result of ordinary course rebalancing transactions in which the Pershing Square Funds purchased and sold Subject Securities among themselves. All of the rebalancing transactions were effected at the same time. There were no changes in the aggregate number of Subject Securities beneficially owned by the Pershing Square Funds as a result of such transactions, and column 5 of Table I specifies that aggregate number.

F4 · price: This Form 4 is being filed as a result of ordinary course rebalancing transactions in which the Pershing Square Funds purchased and sold Subject Securities among themselves. All of the rebalancing transactions were effected at the same time. There were no changes in the aggregate number of Subject Securities beneficially owned by the Pershing Square Funds as a result of such transactions, and column 5 of Table I specifies that aggregate number.

F4 · acquired: This Form 4 is being filed as a result of ordinary course rebalancing transactions in which the Pershing Square Funds purchased and sold Subject Securities among themselves. All of the rebalancing transactions were effected at the same time. There were no changes in the aggregate number of Subject Securities beneficially owned by the Pershing Square Funds as a result of such transactions, and column 5 of Table I specifies that aggregate number.

F4 · balance_after: This Form 4 is being filed as a result of ordinary course rebalancing transactions in which the Pershing Square Funds purchased and sold Subject Securities among themselves. All of the rebalancing transactions were effected at the same time. There were no changes in the aggregate number of Subject Securities beneficially owned by the Pershing Square Funds as a result of such transactions, and column 5 of Table I specifies that aggregate number.

F1 · ownership.nature: In addition to Pershing Square Capital Management, L.P., a Delaware limited partnership ("Pershing Square"), this Form 4 is being filed jointly by PS Management GP, LLC, a Delaware limited liability company ("PS Management"), and William A. Ackman, a citizen of the United States of America (collectively, the "Reporting Persons"), each of whom has the same business address as Pershing Square and may be deemed to have a pecuniary interest in securities reported on this Form 4 (the "Subject Securities").

F2 · ownership.nature: Pershing Square advises the accounts of Pershing Square, L.P., a Delaware limited partnership ("PS"), Pershing Square II, L.P., a Delaware limited partnership ("PS II"), Pershing Square International, Ltd., a Cayman Islands exempted company ("PS International"), and Pershing Square Holdings, Ltd., a limited liability company incorporated in Guernsey ("PSH" and together with PS, PS II and PS International, the "Pershing Square Funds").

F3 · ownership.nature: Pershing Square, as the investment adviser to the Pershing Square Funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. As the general partner of Pershing Square, PS Management may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of William A. Ackman's position as Chief Executive Officer of Pershing Square and managing member of PS Management, William A. Ackman may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

F4 · ownership.nature: This Form 4 is being filed as a result of ordinary course rebalancing transactions in which the Pershing Square Funds purchased and sold Subject Securities among themselves. All of the rebalancing transactions were effected at the same time. There were no changes in the aggregate number of Subject Securities beneficially owned by the Pershing Square Funds as a result of such transactions, and column 5 of Table I specifies that aggregate number.

F5 · ownership.nature: William F. Doyle, a member of the board of directors of the Issuer of the Subject Securities, was elected to that board as a representative of the Reporting Persons, the Pershing Square Funds and Pershing Square GP, LLC. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934.

SEC source: 0000899243-15-000173 · doc4.xml · nonDerivative · entry 1

Pershing Square Capital Management, L.P. · CIK 0001336528 · Director

PS Management GP, LLC · CIK 0001336477 · Director

ACKMAN WILLIAM A · CIK 0001056513 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 41,823,145

F4 · kind: This Form 4 is being filed as a result of ordinary course rebalancing transactions in which the Pershing Square Funds purchased and sold Subject Securities among themselves. All of the rebalancing transactions were effected at the same time. There were no changes in the aggregate number of Subject Securities beneficially owned by the Pershing Square Funds as a result of such transactions, and column 5 of Table I specifies that aggregate number.

F4 · price: This Form 4 is being filed as a result of ordinary course rebalancing transactions in which the Pershing Square Funds purchased and sold Subject Securities among themselves. All of the rebalancing transactions were effected at the same time. There were no changes in the aggregate number of Subject Securities beneficially owned by the Pershing Square Funds as a result of such transactions, and column 5 of Table I specifies that aggregate number.

F4 · acquired: This Form 4 is being filed as a result of ordinary course rebalancing transactions in which the Pershing Square Funds purchased and sold Subject Securities among themselves. All of the rebalancing transactions were effected at the same time. There were no changes in the aggregate number of Subject Securities beneficially owned by the Pershing Square Funds as a result of such transactions, and column 5 of Table I specifies that aggregate number.

F4 · balance_after: This Form 4 is being filed as a result of ordinary course rebalancing transactions in which the Pershing Square Funds purchased and sold Subject Securities among themselves. All of the rebalancing transactions were effected at the same time. There were no changes in the aggregate number of Subject Securities beneficially owned by the Pershing Square Funds as a result of such transactions, and column 5 of Table I specifies that aggregate number.

F1 · ownership.nature: In addition to Pershing Square Capital Management, L.P., a Delaware limited partnership ("Pershing Square"), this Form 4 is being filed jointly by PS Management GP, LLC, a Delaware limited liability company ("PS Management"), and William A. Ackman, a citizen of the United States of America (collectively, the "Reporting Persons"), each of whom has the same business address as Pershing Square and may be deemed to have a pecuniary interest in securities reported on this Form 4 (the "Subject Securities").

F2 · ownership.nature: Pershing Square advises the accounts of Pershing Square, L.P., a Delaware limited partnership ("PS"), Pershing Square II, L.P., a Delaware limited partnership ("PS II"), Pershing Square International, Ltd., a Cayman Islands exempted company ("PS International"), and Pershing Square Holdings, Ltd., a limited liability company incorporated in Guernsey ("PSH" and together with PS, PS II and PS International, the "Pershing Square Funds").

F3 · ownership.nature: Pershing Square, as the investment adviser to the Pershing Square Funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. As the general partner of Pershing Square, PS Management may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of William A. Ackman's position as Chief Executive Officer of Pershing Square and managing member of PS Management, William A. Ackman may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

F4 · ownership.nature: This Form 4 is being filed as a result of ordinary course rebalancing transactions in which the Pershing Square Funds purchased and sold Subject Securities among themselves. All of the rebalancing transactions were effected at the same time. There were no changes in the aggregate number of Subject Securities beneficially owned by the Pershing Square Funds as a result of such transactions, and column 5 of Table I specifies that aggregate number.

F5 · ownership.nature: William F. Doyle, a member of the board of directors of the Issuer of the Subject Securities, was elected to that board as a representative of the Reporting Persons, the Pershing Square Funds and Pershing Square GP, LLC. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934.

SEC source: 0001555280-18-000067 · wf-form4a_151873241026657.xml · nonDerivative · entry 1

Sanjay Khosla · CIK 0001387531 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9.5193

F1 · security: This transaction is not new or revised, but is being reported again solely in order to file the attached Power of Attorney, which was inadvertently omitted from the reporting person's original Form 4 filed on November 6, 2013.

F2 · shares: These shares represent dividend equivalent units, which were automatically issued pursuant to deferred stock units previously granted to the reporting person under the Zoetis Inc. 2013 Equity and Incentive Plan. The dividend equivalent units are fully vested and will be settled in shares of Zoetis common stock following the reporting person's separation from service at Zoetis.

F2 · balance_after: These shares represent dividend equivalent units, which were automatically issued pursuant to deferred stock units previously granted to the reporting person under the Zoetis Inc. 2013 Equity and Incentive Plan. The dividend equivalent units are fully vested and will be settled in shares of Zoetis common stock following the reporting person's separation from service at Zoetis.

SEC source: 0000078003-13-000014 · primary_doc.xml · derivative · entry 3

PFIZER INC · CIK 0000078003 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 400,985,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Class B Common Stock was convertible into Class A Common Stock at any time on a one-for-one basis and had no exercise or conversion price or expiration date.

F3 · derivative.exercise_date: The Class B Common Stock was convertible into Class A Common Stock at any time on a one-for-one basis and had no exercise or conversion price or expiration date.

F3 · derivative.expiration_date: The Class B Common Stock was convertible into Class A Common Stock at any time on a one-for-one basis and had no exercise or conversion price or expiration date.

SEC source: 0000078003-13-000014 · primary_doc.xml · nonDerivative · entry 2

PFIZER INC · CIK 0000078003 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: Pfizer Inc. ("Pfizer") disposed of 400,985,000 shares of Class A Common Stock of Zoetis Inc. ("Class A Common Stock") in exchange for 405,117,195 shares of Pfizer common stock pursuant to a registered exchange offer to Pfizer common stockholders. The final exchange ratio for the exchange offer was 0.9898 shares of Class A Common Stock per share of Pfizer common stock accepted in the exchange offer. As a result of the exchange offer, Pfizer has disposed of its entire equity interest in the Issuer. The closing price of Pfizer common stock on the New York Stock Exchange on June 21, 2013, the trading day immediately preceding the day on which Pfizer accepted Pfizer shares that had been validly tendered and not validly withdrawn,was $28.46.

SEC source: 0000078003-13-000014 · primary_doc.xml · nonDerivative · entry 1

PFIZER INC · CIK 0000078003 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,985,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Class A Common Stock was acquired pursuant to the conversion of Class B Common Stock in an exempt transaction under Rule 16b-6(b). The Class B Common Stock was converted into Class A Common Stock on a one-for-one basis and had no exercise or conversion price.

F3 · price: The Class B Common Stock was convertible into Class A Common Stock at any time on a one-for-one basis and had no exercise or conversion price or expiration date.

SEC source: 0001209191-13-007372 · doc4.xml · derivative · entry 3

PFIZER INC · CIK 0000078003 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,985,000

Underlying: Class A Common Stock · 12,915,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each share of Class B Common Stock held by Pfizer Inc. or one of its subsidiaries will be convertible into one share of Class A Common Stock at any time but will not be convertible if held by any other holder.

F4 · derivative.exercise_date: Each share of Class B Common Stock held by Pfizer Inc. or one of its subsidiaries will be convertible into one share of Class A Common Stock at any time but will not be convertible if held by any other holder.

F4 · derivative.expiration_date: Each share of Class B Common Stock held by Pfizer Inc. or one of its subsidiaries will be convertible into one share of Class A Common Stock at any time but will not be convertible if held by any other holder.

F2 · ownership.direct: Pfizer Inc. may be deemed a director of the Issuer on the basis of its relationship with five of the directors of the Issuer.

SEC source: 0001209191-13-007372 · doc4.xml · nonDerivative · entry 2

PFIZER INC · CIK 0000078003 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F3 · price: Pfizer Inc. disposed of 99,015,000 shares of Class A Common Stock in exchange for outstanding debt obligations of Pfizer Inc. The debt obligations were valued at their fair market value, and the fair market value of the debt obligations exchanged equaled $25.038 per share of Class A Common Stock exchanged.

F2 · ownership.direct: Pfizer Inc. may be deemed a director of the Issuer on the basis of its relationship with five of the directors of the Issuer.

SEC source: 0001209191-13-007372 · doc4.xml · nonDerivative · entry 1

PFIZER INC · CIK 0000078003 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,915,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Class A Common Stock was acquired pursuant to the conversion of Class B Common Stock in an exempt transaction under the Exchange Act Rule 16b-6(b). The Class B Common Stock was converted into Class A Common Stock on a one-for-one basis and had no exercise or conversion price.

F2 · ownership.direct: Pfizer Inc. may be deemed a director of the Issuer on the basis of its relationship with five of the directors of the Issuer.